Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „prolongation“
Suchtreffer
Begriffe & Kennungen
Fareston · 4.5 · An additive effect on QT interval prolongation between Fareston and the following drugs and other medicinal pr
Eintrag öffnenFarydak · 4.5 · Prolongation of QT interval Based on preclinical and clinical data, panobinostat has the potential to prolong
Eintrag öffnenFarydak · 4.8 · QT prolongation and ECG abnormalities QTc prolongation was observed and was mostly mild in degree: QTcF interv
Eintrag öffnenFuzeon · 4.8 · severe pain requiring hospitalisation or prolongation of hospitalisation, resulting in death, or persistent or
Eintrag öffnenIntuniv · 4.8 · In phase II-III randomised double-blind monotherapy studies respective increases in QTc interval prolongation
Eintrag öffnenIntuniv · 4.8 · QT/QTc interval prolongation
Eintrag öffnenInvega · 4.8 · Class effects QT prolongation, ventricular arrythmias (ventricular fibrillation, ventricular tachycardia), sud
Eintrag öffnenKaletra · 4.5 · 18 Delamanid (100 mg BID) Delamanid: Due to the risk of QTc prolongation AUC: ↑ 22% associated with DM-6705, i
Eintrag öffnenKaletra · 4.5 · 54 Delamanid (100 mg Delamanid: Due to the risk of QTc prolongation BID) AUC: ↑ 22% associated with DM-6705, i
Eintrag öffnenKaletra · 4.5 · Delamanid (100 mg Delamanid: Due to the risk of QTc prolongation BID) AUC: ↑ 22% associated with DM-6705, if c
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA) · 4.5 · Monitoring of QT-prolongation if used concomitantly. Bortezomib Bortezomib: Careful monitoring. Busulfan AUC:
Eintrag öffnenKisqali · 4.8 · QT prolongation In the phase III study in patients with early breast cancer, 5.3% of patients in the Kisqali p
Eintrag öffnenKrazati · 4.8 · QT interval prolongation resulted in dose interruption and/or reduction in 3.4% of patients (see sections 4.2
Eintrag öffnenKrazati · 4.8 · QT prolongation Any grade increase in QTcF interval from baseline occurred in 43.9% of patients. Increase in Q
Eintrag öffnenLebenserhaltende Behandlung
Eintrag öffnenLenvima · 4.8 · Females had a higher incidence of hypertension, fatigue, ECG QT prolongation and alopecia. Men had a higher in
Eintrag öffnenLenvima · 4.8 · In the Phase 3 REFLECT trial (see section 5.1), QT/QTc interval prolongation was reported in 6.9% of lenvatini
Eintrag öffnenLenvima · 4.8 · In the Phase 3 Study 309 (see section 5.1), QT interval prolongation was reported in 3.9% of lenvatinib plus p
Eintrag öffnenLenvima · 4.8 · In the pivotal Phase 3 SELECT trial (see section 5.1), QT/QTc interval prolongation was reported in 8.8% of le
Eintrag öffnenLenvima · 4.8 · QT interval prolongation (see section 4.4)
Eintrag öffnen